The Company is a Korea-based company mainly engaged in the development and sale of pharmaceuticals. The Company operates its business through two segments. The New Drug Development segment is involved in the development and sale of diabetes treatment, obesity treatment, osteoporosis treatment, alzheimer s disease treatment, and autoimmune enhancers. The Health Functional Food segment is engaged in the manufacturing and sale of health functional food related to blood sugar, prostate health, comprehensive minerals, and cognitive improvement. It also produces and sells vinegar drinks. The Company distributes its products within the domestic market and to overseas markets, including America and China. The Company was founded on Novembe 04 , 2010. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on October 28, 2015.
Headquarters
Trees Bldg., 727, Eonju-Ro, Gangnam-Gu
Seoul; Seoul;
Contact Details: Purchase the Novmetapharma Co. Ltd. report to view the information.
Website: http://www.novmeta.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service